# Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer

> **NCT02835404** · PHASE2 · UNKNOWN · sponsor: **Daping Hospital and the Research Institute of Surgery of the Third Military Medical University** · enrollment: 200 (estimated)

## Conditions studied

- Cervical Cancer
- Complications

## Interventions

- **DRUG:** Nedaplatin
- **RADIATION:** Pelvic External Radiotherapy
- **RADIATION:** 252-Cf Neutron Intracavitary Brachytherapy

## Key facts

- **NCT ID:** NCT02835404
- **Lead sponsor:** Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2017-06
- **Final completion:** 2018-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2016-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02835404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02835404, "Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02835404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
